Introduction

In the face of increasing droughts and extreme weather caused by global climate change, the world needs to find a way to sustainably feed a world population that is forecast to grow by an additional 2 billion people over the next 30 years.

Our scientific discoveries are the basis for a rapidly expanding intellectual property portfolio based on multiple organic priming elicitors, how they work in plants, and their product applications.

Zero Gravity Solutions is on a mission to unlock the natural power of plants to increase agricultural yields while limiting the use of potentially harmful synthetic chemicals.

By “priming” the plant’s natural physiology, our company’s technology has been shown to significantly improve crop yields, manage disease, and mitigate stress. After 7+ years of research, 65+ field trials across 35+ crop varieties, Zero Gravity has two products with sales from major distributors including Rite-Aid. Over the next two years, we plan additional product launches and further expansion into larger product sectors.

Success To Date

  • One of the first companies to uniquely advance plant priming technology
  • 7+ Years of R&D progress
  • 65+ Studies and field trials
  • 35+ Crop varieties with promising trial results
  • 5 Distributor partnerships
  • 2 Products on market with registration in 4 countries and all 50 states
  • 2 Patents filed, with more in the works

Problem

Now is a critical time for the $3.5T global agriculture industry, beset by unprecedented challenges, and in need of producing more with less. With consumers facing the reality of food shortages and rapidly rising prices at the grocery store, the world’s population continues to grow. It just reached 8 billion in mid-November 2022, and the UN forecasts that population may grow by another 2 billion people in the next 30 years.

We urgently need to find a way to feed more people, more affordably, and more sustainably. And we need to do this all while using less resources.

Solution

Zero Gravity’s priming technology may enable a new category of agricultural products that deliver a uniquely broad set of benefits.

Our products have the potential to become a new foundational technology that farmers broadly use to improve plant health and quality, increase yields, and reduce the need for less sustainable inputs. The result for farmers may be increased profitability and more sustainable farming practices.

“I’m very excited to add a product as technically advanced as BAM-FX to my farming program. BAM-FX increased the overall health of my spring wheat plant with wider leaves, thicker stems, and a more developed root. This increased my yield helping my bottom line in these tough economic times.”
- Ron Chernenko
Farmer, Grassy Butte, ND

Technology

Zero Gravity’s scientific discoveries have created a unique understanding of multiple organic priming elicitors that are part of plants’ natural physiology. These natural elements activate plants’ defenses to respond to stress, combat disease, and increase crop yield – similar to how a shot can boost humans’ immune system to fight the flu.

Our technology enables farmers to proactively manage plant “priming” in order to increase agricultural productivity while supporting more sustainable production practices.

We are unlocking the natural power of plants.

Plants have a natural ability to protect themselves from stress and disease, but the natural response is often too slow or weak. Zero Gravity’s pioneering priming technology enables a plant to respond more quickly and strongly, much like a human vaccine. By activating a plant’s natural defenses, farmers can sustainably increase yields while reducing the need for more expensive inputs. Our technology may help the $3.5T global agriculture industry produce enough to feed a hungry world. 

Field Trial Results

Zero Gravity’s novel technology has been shown to significantly improve crop yields by enhancing and optimizing a plant’s natural response to environmental stressors including common plant pathogens by “priming” a plant’s natural physiology. Strong field results create many opportunities to launch new products with broad market potential.

Product Pipeline

Our tech platform is developing an increasingly deep pipeline of near-term products:

Products

Zero Gravity has launched two products since 2020, with new formulations and applications currently in development. First product sales show the promise and appeal of our technology, and our products including:

  1. BAM-FX, for commercial agriculture
  2. Gardener’s Choice, for retail home & garden
“I have been seeking an agricultural technology that represents a breakthrough in fortifying plant health and creating a ‘natural resistance’ to help increase yield and plant vigor. Upon my review of five years of BAM-FX plant trials, including collaborative work with NASA and three flights to the ISS, I am convinced that BAM-FX has the potential to launch a new era of agricultural science, the next step beyond organic.”
– Rohan Marley
Entrepreneur, coffee farmer, BAM-FX ambassador, and son of Bob Marley

Business Model

Zero Gravity is rapidly developing our technology into a platform and IP portfolio for broad commercialization.

Our tech platform integrates internal R&D with collaborative partner testing to create a positive feedback loop for iterative, accelerated development. Zero Gravity is creating IP in the form of new technology, applications, and products. Our business model leverages multiple potential avenues for monetizing our IP to maximize value creation from product distribution and sales, commercial partnerships, and licensing agreements.

Market

Zero Gravity’s technology has broad benefits for sustainable and organic agriculture, a $150B+ global market. Our first two products target the micronutrients and plant stimulants markets, worth nearly $10B globally. These markets have relatively low barriers to entry and existing competitive products tend to struggle with short shelf-life and inconsistent efficacy.

Our priming technology is designed to avoid these problems and offers wider benefits than traditional products.

Our strategy builds on our success in smaller markets to expand to larger markets. Initial trials show the potential for our priming effect to help control crop diseases, some of which have no current solution on the market, such as citrus greening (Huanglongbing). Zero Gravity is actively engaging in product development to expand the application of our technology to disease management, a $20B+ global market. Additional research is aimed at further expanding to wider applications in sustainable agriculture.

Team

John McLean
CEO
John is an agriculture industry executive with 40 years of diverse industry experience including as COO of Monsanto Growth Ventures and as President of Intrexon Crop Protection.

Ravi Pottathil
CTO
Ravi is an entrepreneur with a 40-year history spanning industry & academia, covering biochemistry, molecular biology, mammalian genetics, medical virology, tumor biology, and diagnostics.


Kathy Conway
Head of Operations
Agbiotech leader with 35 years of experience in strategic operations, driving companies the next stage of growth from product development through commercialization
Matt Cleaver
Head of Business Development
Business development and strategy leader with over a decade of experience driving growth and performance across multiple businesses in the food and agriculture industry.
Rik Miller
Commercial Advisor
Rik has 40+ years of experience in production agriculture including as President of Crop Protection at Dupont and senior leadership positions in sales, marketing, portfolio management, and business operations.

Brad Shurdut
Regulatory Advisor
Brad is an attorney and senior life sciences, biotechnology, and ag industry executive with 30+ years of experience in government affairs, regulatory affairs, public policy, environmental health & safety, and risk assessment.

Use of Proceeds


If the offering's maximum amount of $1,235,000 is raised:

UseValue% of Proceeds
IP and Product Development$617,50050.0%
Distributor Support$123,50010.0%
R&D Collaboration and Licensing$123,50010.0%
Production$123,50010.0%
Corporate Governance and Compliance$186,48515.1%
Intermediary fees$60,5154.9%

Terms

This is an offering of Common Stock, under registration exemption 4(a)(6), in Zero Gravity Solutions, Inc.. This offering must raise at least $10,000 by April 29, 2024 at 10:59pm ET. If this offering doesn’t reach its target, then your money will be refunded. Zero Gravity Solutions may issue additional securities to raise up to $1,235,000, the offering’s maximum.

If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:

50,271,448 shares
×
$1 per share
$50,271,448implied valuation

Financials

These financial statements have been reviewed by an independent Certified Public Accountant.

SEC Filings

The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.

We’re also required to share links to each of the SEC filings related to this offering with investors.

Understand the Risks

Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.

Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

More Info

Updates

  • Apr 30, 2024
    Primary offering finalized, selling 359,156 shares
    Sold 359,156 shares at $1 for a total of $359,156
  • Mar 19, 2024
    Primary offering of 1,235,000 shares at $1
  • Mar 19, 2024

Ask a Question

Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.

Looking to raise capital?
We can help turn your friends, family and customers into investors.

Learn more

Interested in more investment opportunities?
Browse all offerings currently available.

See more